Clinical Phenotype and Response to Imatinib of Chronic Myelogenous Leukemia Patients Harbouring Atypical BCR-ABL Transcripts. A Retrospective Analysis From the French Group of CML (Fi-LMC) and the French Group of Molecular Biologists for Hematological Malignancies (GBMHM).

Autor: Deau, Benedicte *, Montveneur, Mathias *, Coiteux, Valérie *, Renneville, Aline *, Rigal-Huguet, Francoise *, Delabesse, Eric *, Tulliez, Michel *, Bories, Dominique *, Charbonnier, Aude *, Mozziconacci, Marie-Joelle *, Legay, Thibault *, Lippert, Eric *, Mahon, Francois-Xavier, Rea, Delphine *, Cayuela, Jean-Michel *, Amé, Shanti *, Gaub, Marie-Pierre *, Gardembas, Martine *, Blanchet, Odile *, Audhuy, Bruno *, Buzyn, Agnès *, Intyre, Elisabeth Mac *, Andreoli, Anna-Lisa *, Reman, Oumedaly, Contentin, Nathalie *, Bastard, Christian *, Ianotto, Jean-Christophe *, Ugo, Valérie *, Kiladjian, Jean-Jacques *, Brahimi, Said *, Dubruille, Viviane *, Brantus, Jean-Francois *, Sobh, Mohamad *, Morisset, Stephane *, Preudhomme, Claude *, Hayette, Sandrine *, Nicolini, Franck E
Zdroj: In Blood 19 November 2010 116(21):3378-3378
Databáze: ScienceDirect